Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

IVA Technologies and RT-Invest Transportation Systems agree on partnership

9/30/24 IVAT

Fesco launched a service for the delivery of goods from Asia

9/30/24 FESH

Shareholders of Magnitogorsk Iron and Steel Works approved dividends for 6 months 2024

9/30/24 MAGN

Trading volume on SPB Exchange in the 1st half of the year decreased 34 times

9/27/24 SPBE

Kamaz sales in the 1st half of the year decreased by 20%

9/27/24 KMAZ

RusHydro raises ₽79 billion to expand Partizanskaya GRES

9/27/24 HYDR

Lukoil reduced hydrocarbon production by 1%

9/27/24 LKOH

Yandex will bring to the streets thousands of electric bicycles of its own design

9/27/24 YDEX

Solidcore finalized the exchange of blocked shares

9/27/24 POLY

Novabev Group registered a brand for non-alcoholic products

9/27/24 BELU